Effectiveness and Safety of Probiotic in Regulating Chronic Constipation
Chronic Constipation
About this trial
This is an interventional treatment trial for Chronic Constipation focused on measuring Probiotics;Chronic constipation
Eligibility Criteria
Inclusion Criteria: Patients with chronic constipation (duration more than 3 months with less than three bowel movements per week and/or Bristol Scale 1 and 2). Exclusion Criteria: Diabetic patients. Pregnant patients. Breastfeeding patients. Patients requiring antibiotic treatment. Patients requiring treatment with tricyclic antidepressants, antiepileptics, antihistamines, antiparkinsonians, antipsychotics, antispasmodics, verapamil, monoamine oxidase inhibitors, opiates, sympathomimetics, antacids (with aluminum and calcium), antidiarrheals and nonsteroidal anti-inflammatory drugs. Patients who change the type of diet during the study. Patients with allergy or intolerance to any of the ingredients in the formulation of the product under study. Subjects with a history of pharmacological, alcoholic, or other substance abuse, or other factors that limit their ability to cooperate during the study. Excessive alcohol consumption (>3 glasses of wine or beer/day). Subjects whose condition does not make them eligible for the study, according to the researcher.
Sites / Locations
- CAP Can Bou Castelldefels and CAP Corbera de Llobregat
- Family and Community Medicine CAP Roger
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Probiotic group
placebo
2B CFU/capsule/day BLa80, before meals; Storage: Store in a cool, dry place without sun exposure.
Maltodextrin, one capsule/day, before meals; Storage: Store in a cool, dry place without exposure to the sun.